Forma Therapeutics Holdings, Inc. Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Forma Therapeutics Holdings, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Forma Therapeutics Holdings, Inc. for March 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 02 2021 | FMTX | Forma Therapeutics ... | Potts Jeannette | See Remarks | Option Exercise | A | 38.61 | 43,550 | 1,681,466 | 43,550 | |
Mar 02 2021 | FMTX | Forma Therapeutics ... | Potts Jeannette | See Remarks | Grant | A | 0.00 | 9,330 | 0 | 27,030 | 17.7 K to 27 K (+52.71 %) |
Mar 02 2021 | FMTX | Forma Therapeutics ... | Potts Jeannette | See Remarks | Grant | A | 0.00 | 14,300 | 0 | 17,700 | 3.4 K to 17.7 K (+420.59 %) |
Mar 02 2021 | FMTX | Forma Therapeutics ... | Wadlinger Mary E. | See Remarks | Option Exercise | A | 38.61 | 43,550 | 1,681,466 | 43,550 | |
Mar 02 2021 | FMTX | Forma Therapeutics ... | Wadlinger Mary E. | See Remarks | Grant | A | 0.00 | 9,330 | 0 | 139,205 | 129.9 K to 139.2 K (+7.18 %) |
Mar 02 2021 | FMTX | Forma Therapeutics ... | Wadlinger Mary E. | See Remarks | Grant | A | 0.00 | 14,300 | 0 | 129,875 | 115.6 K to 129.9 K (+12.37 %) |
Mar 02 2021 | FMTX | Forma Therapeutics ... | COOK DAVID N | SVP, Chief Scientif ... | Option Exercise | A | 38.61 | 43,550 | 1,681,466 | 43,550 | |
Mar 02 2021 | FMTX | Forma Therapeutics ... | COOK DAVID N | SVP, Chief Scientif ... | Grant | A | 0.00 | 5,700 | 0 | 20,000 | 14.3 K to 20 K (+39.86 %) |
Mar 02 2021 | FMTX | Forma Therapeutics ... | COOK DAVID N | SVP, Chief Scientif ... | Grant | A | 0.00 | 14,300 | 0 | 14,300 | 0 to 14.3 K |
Mar 02 2021 | FMTX | Forma Therapeutics ... | Shegog Todd | SVP, Chief Financia ... | Option Exercise | A | 38.61 | 50,250 | 1,940,153 | 0 | |
Mar 02 2021 | FMTX | Forma Therapeutics ... | Shegog Todd | SVP, Chief Financia ... | Grant | A | 0.00 | 12,000 | 0 | 28,500 | 16.5 K to 28.5 K (+72.73 %) |
Mar 02 2021 | FMTX | Forma Therapeutics ... | Shegog Todd | SVP, Chief Financia ... | Grant | A | 0.00 | 16,500 | 0 | 16,500 | 0 to 16.5 K |
Mar 02 2021 | FMTX | Forma Therapeutics ... | Lee Frank D. | President and CEO | Option Exercise | A | 38.61 | 175,875 | 6,790,534 | 175,875 | |
Mar 02 2021 | FMTX | Forma Therapeutics ... | Lee Frank D. | President and CEO | Grant | A | 0.00 | 40,000 | 0 | 97,750 | 57.8 K to 97.8 K (+69.26 %) |
Mar 02 2021 | FMTX | Forma Therapeutics ... | Lee Frank D. | President and CEO | Grant | A | 0.00 | 57,750 | 0 | 57,750 | 0 to 57.8 K |
Mar 02 2021 | FMTX | Forma Therapeutics ... | Kelly Patrick F. | Chief Medical Offic ... | Option Exercise | A | 38.61 | 50,250 | 1,940,153 | 50,250 | |
Mar 02 2021 | FMTX | Forma Therapeutics ... | Kelly Patrick F. | Chief Medical Offic ... | Grant | A | 0.00 | 10,670 | 0 | 27,170 | 16.5 K to 27.2 K (+64.67 %) |
Mar 02 2021 | FMTX | Forma Therapeutics ... | Kelly Patrick F. | Chief Medical Offic ... | Grant | A | 0.00 | 16,500 | 0 | 16,500 | 0 to 16.5 K |